Neurocreate Investors
NeuroCreate's AI-driven neuroscience-designed platform augments creativity and enhances mental health
Connections from
Headquarters:
London, England, United Kingdom
Founded Date:
2017
Investor Type:
Healthcare Company
Technology:
NeuroTech
Employee Number:
1-10
Industry:
NeuroTech Augmentation (Tech and Pharma)




